Flumazenil reversal of psychomotor impairment due to midazolam or diazepam for conscious sedation for upper endoscopy
Open Access
- 31 October 1996
- journal article
- clinical trial
- Published by Elsevier BV in Gastrointestinal Endoscopy
- Vol. 44 (4), 416-421
- https://doi.org/10.1016/s0016-5107(96)70091-3
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Routine use of Flumazenil (FMZ) with conscious sedation shortens recovery time for Gastrointestinal (GI) endoscopic proceduresGastrointestinal Endoscopy, 1995
- Comparison of sedative recovery time after midazolam versus diazepam administrationCritical Care Medicine, 1994
- Prospective evaluation of complications in an endoscopy unit: use of the A/S/G/E quality care guidelinesGastrointestinal Endoscopy, 1992
- Results from the American Society for Gastrointestinal Endoscopy/U.S. Food and Drug Administration collaborative study on complication rates and drug use during gastrointestinal endoscopyGastrointestinal Endoscopy, 1991
- The value of flumazenil in the reversal of midazolam‐induced sedation for upper gastrointestinal endoscopyAlimentary Pharmacology & Therapeutics, 1990
- Double-blind controlled trial of flumazenil in patients who underwent upper gastrointestinal endoscopyGastrointestinal Endoscopy, 1989
- Premedication for upper gastrointestinal endoscopyGastrointestinal Endoscopy, 1989
- Flumazenil used for antagonizing the central effects of midazolam and diazepam in outpatientsActa Anaesthesiologica Scandinavica, 1989
- Benzodiazepine antagonist Ro 15‐1788Anaesthesia, 1986
- Amnesic action of midazolamAnaesthesia, 1980